Evidence map›Paper›PMID 28758136›Full record

ArticleArchives of neuroscience2017

A mouse Model of Focal Vascular Injury Induces Astrocyte Reactivity, Tau Oligomers, and Aberrant Behavior.

Aric F Logsdon, Brandon P Lucke-Wold, Ryan C Turner, Xinlan Li, Chris E Adkins, Afroz S Mohammad, Jason D Huber, Charles L Rosen, Paul R Lockman

Abstract read
In one paragraph

Article in Archives of neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Altered Serotonin 2A (5-HTFrontiers in pharmacology · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aric F LogsdonDepartment of Pharmaceutical Sciences, West Virginia University School of Medicine, Morgantown, WV 26506-9530, USA.
Brandon P Lucke-WoldDepartment of Neurosurgery, West Virginia University School of Medicine, Morgantown, WV 26506-9183, USA.
Ryan C TurnerDepartment of Neurosurgery, West Virginia University School of Medicine, Morgantown, WV 26506-9183, USA.
Xinlan LiDepartment of Neurosurgery, West Virginia University School of Medicine, Morgantown, WV 26506-9183, USA.
Chris E AdkinsDepartment of Pharmaceutical Sciences, West Virginia University School of Medicine, Morgantown, WV 26506-9530, USA.
Afroz S MohammadDepartment of Pharmaceutical Sciences, West Virginia University School of Medicine, Morgantown, WV 26506-9530, USA.
Jason D HuberDepartment of Pharmaceutical Sciences, West Virginia University School of Medicine, Morgantown, WV 26506-9530, USA.
Charles L RosenDepartment of Neurosurgery, West Virginia University School of Medicine, Morgantown, WV 26506-9183, USA.
Paul R LockmanDepartment of Pharmaceutical Sciences, West Virginia University School of Medicine, Morgantown, WV 26506-9530, USA.

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
Therapeutic use of bryostatin-1 to extend tPA time window following MCAOR01NS099918 · NINDS · WEST VIRGINIA UNIVERSITY · PI HUBER, JASON D · 2017 to 2021
$1.6M
Prevention and treatment of brain micrometastases of breast cancerR01CA166067 · NCI · WEST VIRGINIA UNIVERSITY · PI LOCKMAN, PAUL R · 2013 to 2017
$1.5M
NCI NIH HHS R01 CA166067NIGMS NIH HHS U54 GM104942NINDS NIH HHS R01 NS099918
6 · The paper itself

Abstract

Neuropsychiatric symptom development has become more prevalent with 270,000 blast exposures occurring in the past 10 years in the United States. How blast injury leads to neuropsychiatric symptomology is currently unknown. Preclinical models of blast-induced traumatic brain injury have been used to demonstrate blood-brain barrier disruption, degenerative pathophysiology, and behavioral deficits. Vascular injury is a primary effect of neurotrauma that can trigger secondary injury cascades and neurodegeneration. Here we present data from a novel scaled and clinically relevant mouse blast model that was specifically developed to assess the outcome of vascular injury. We look at the biochemical effects and behavioral changes associated with blast injury in young-adult male BALB/c mice. We report that blast exposure causes focal vascular injury in the Somatosensory Barrel Field cortex, which leads to perivascular astrocyte reactivity, as well as acute aberrant behavior. Biochemical analysis revealed that mild blast exposure also invokes tauopathy, neuroinflammation, and oxidative stress. Overall, we propose our model to be used to evaluate focal blood-brain barrier disruption and to discover novel therapies for human neuropsychiatric symptoms.

Indexed as

Astrocyte ReactivityBlood-Brain Barrier DisruptionNeuropsychiatric BehaviorTauopathyTraumatic Brain Injury

Identifiers

PMID28758136
PMCPMC5529099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.